Retraction

Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

See also: https://pubpeer.com/publications/0789686E467B5D8BAC2D48AB36E507

Citations (3)

3
Total Citations
1
Post-Retraction
(33.3%)
1
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
361 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Serum exosomal <scp>miR</scp>‐16‐5p functions as a tumor inhibitor and a new biomarker for <scp>PD‐L1</scp> inhibitor‐dependent immunotherapy in lung adenocarcinoma by regulating <scp>PD‐L1</scp> expression
Hua‐Lin Chen, Yi‐Ping Luo, Mu‐Wen Lin et al. (9 authors)
Cancer Medicine Open Access
Published: Mar 2022
25 citations
361 days after retraction
microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2
Xianpeng Ma, Di Wu, Xu Dong Zhang et al. (5 authors)
Technology in Cancer Research & Treatment Open Access
Published: Jan 2020
8 citations
456 days before retraction
Quick Stats
Total Citations: 7
Years Since Retraction: 4.6 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Effect of propofol on myocardial ischemia-reperfusion injur…
European Review for Medical and Pharmacological Sciences • 19 citations
MiR-299-3p inhibits proliferation and invasion of cervical …
European Review for Medical and Pharmacological Sciences • 19 citations
Aldose reductase inhibitor Epalrestat alleviates high gluco…
European Review for Medical and Pharmacological Sciences • 18 citations
MiR-15a-3p suppresses the growth and metastasis of ovarian …
European Review for Medical and Pharmacological Sciences • 18 citations
The inhibitory effect of miR-375 targeting sp1 in colorecta…
European Review for Medical and Pharmacological Sciences • 18 citations